BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8278422)

  • 1. The use of insulin in diabetes mellitus.
    Jacques A
    Prof Nurse; 1993 Dec; 9(3):190-2. PubMed ID: 8278422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin therapy in children and adolescents with Type 1 diabetes.
    McAssey K; Perlman K; Daneman D
    Diabetes Nutr Metab; 1999 Apr; 12(2):86-95. PubMed ID: 10554891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eighty years of insulin therapy: 1922-2002.
    Levinson PD
    Med Health R I; 2003 Apr; 86(4):101-6. PubMed ID: 12751363
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin therapy].
    Brunetti P
    Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Devices for insulin administration.
    Hill J
    Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can amylin analogue lead to better diabetes control?
    Morrow T
    Manag Care; 2003 Dec; 12(12):40-1. PubMed ID: 14723102
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monocomponent human insulin and amino acid metabolism in type I diabetes mellitus].
    Lugari R; Nicolotti V; Montanari A; Borghi L; Dall'Argine P; Novarini A; Gnudi A
    Minerva Endocrinol; 1984; 9(2):137-9. PubMed ID: 6390127
    [No Abstract]   [Full Text] [Related]  

  • 12. Noninjectable methods of insulin administration.
    Cernea S; Raz I
    Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E29. PubMed ID: 17136235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ; Cohen H; Chu V
    J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin detemir--a new basal insulin analog.
    Goldman-Levine JD; Lee KW
    Ann Pharmacother; 2005 Mar; 39(3):502-7. PubMed ID: 15657117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A; Zantout MS; Azar ST
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
    Crasto W; Jarvis J; Khunti K; Davies MJ
    Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive insulin treatment in diabetic children.
    Ludvigsson J; Bolli GB
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment.
    Federiuk IF; Casey HM; Quinn MJ; Wood MD; Ward WK
    Comp Med; 2004 Jun; 54(3):252-7. PubMed ID: 15253270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway.
    Cliffe ST; Kramer JM; Hussain K; Robben JH; de Jong EK; de Brouwer AP; Nibbeling E; Kamsteeg EJ; Wong M; Prendiville J; James C; Padidela R; Becknell C; van Bokhoven H; Deen PM; Hennekam RC; Lindeman R; Schenck A; Roscioli T; Buckley MF
    Hum Mol Genet; 2009 Jun; 18(12):2257-65. PubMed ID: 19336477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.